Shanxi Medical University, Taiyuan, Shanxi, China.
Heart Center, Beijing Chao-Yang Hospital, Capital Medical University, Beijing, China.
J Interv Card Electrophysiol. 2024 Sep;67(6):1377-1390. doi: 10.1007/s10840-024-01742-w. Epub 2024 Jan 16.
The current evidence on the use of laryngeal mask airway (LMA) as an airway management technique for general anesthesia (GA) during atrial fibrillation (AF) catheter ablation (CA) is insufficient. This study aims to compare the feasibility, safety, and clinical benefits of LMA and endotracheal intubation (ETI) for airway management in AF CA.
One hundred fifty-two consecutive patients with AF who underwent CA under GA were included and divided into two groups based on different airway management methods (66 in the LMA group, 86 in the ETI group). After propensity score matching, a final analysis cohort of 132 patients was obtained to compare procedural parameters, adverse events, and prognosis between the two groups.
The LMA group exhibited significantly shorter total procedural time (p = 0.039), anesthesia induction time (p = 0.015), and recovery time (p = 0.006) compared to the ETI group. The mean arterial pressure (MAP) and heart rate were significantly lower in the LMA group during extubation and 1-min post-extubation (p < 0.05). Furthermore, the LMA group demonstrated lower MAP levels during intubation (p = 0.029). The incidences of intraoperative hypotension (p = 0.017) and bradycardia (p = 0.032) were significantly lower in the LMA group. The incidences of delayed recovery or delirium (p = 0.027), laryngeal or airway injury (p = 0.016), cough or bucking (p = 0.001), and sore throat (p < 0.001) were significantly lower in the LMA group. There were no statistically significant differences in catheter stability parameters and sinus rhythm maintenance rates between the two groups (p > 0.05).
LMA is feasible, safe, and effective in AF CA as an optimized airway management technique for GA.
目前关于在心房颤动(AF)导管消融(CA)期间全身麻醉(GA)中使用喉罩气道(LMA)作为气道管理技术的证据不足。本研究旨在比较 LMA 和气管内插管(ETI)在 AF CA 中气道管理的可行性、安全性和临床获益。
纳入了 152 例接受 GA 下 CA 的连续 AF 患者,并根据不同的气道管理方法将其分为两组(LMA 组 66 例,ETI 组 86 例)。在进行倾向评分匹配后,获得了最终分析队列中的 132 例患者,以比较两组之间的程序参数、不良事件和预后。
与 ETI 组相比,LMA 组的总手术时间(p = 0.039)、麻醉诱导时间(p = 0.015)和恢复时间(p = 0.006)明显更短。LMA 组在拔管和拔管后 1 分钟时的平均动脉压(MAP)和心率明显较低(p < 0.05)。此外,LMA 组在插管期间的 MAP 水平较低(p = 0.029)。术中低血压(p = 0.017)和心动过缓(p = 0.032)的发生率在 LMA 组明显较低。LMA 组延迟恢复或谵妄(p = 0.027)、喉或气道损伤(p = 0.016)、咳嗽或颠簸(p = 0.001)和咽喉痛(p < 0.001)的发生率明显较低。两组之间导管稳定性参数和窦性节律维持率无统计学差异(p > 0.05)。
LMA 是可行的、安全的,在 AF CA 中作为 GA 的优化气道管理技术是有效的。